0001671687-16-000001.txt : 20160411 0001671687-16-000001.hdr.sgml : 20160411 20160411123923 ACCESSION NUMBER: 0001671687-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20160411 DATE AS OF CHANGE: 20160411 EFFECTIVENESS DATE: 20160411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vividion Therapeutics, Inc. CENTRAL INDEX KEY: 0001671687 IRS NUMBER: 464373293 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261009 FILM NUMBER: 161564649 BUSINESS ADDRESS: STREET 1: 230 NASSAU STREET CITY: PRINCETON STATE: NJ ZIP: 08542 BUSINESS PHONE: 6099246452 MAIL ADDRESS: STREET 1: 230 NASSAU STREET CITY: PRINCETON STATE: NJ ZIP: 08542 D 1 primary_doc.xml X0707 D LIVE 0001671687 Vividion Therapeutics, Inc. 230 NASSAU STREET PRINCETON NJ NEW JERSEY 08542 6099246452 DELAWARE None None Corporation true 2013 John K. Clarke c/o Cardinal Partners, 230 Nassau Street Princeton NJ NEW JERSEY 08542 Executive Officer Director John Park c/o Cardinal Partners, 230 Nassau Street Princeton NJ NEW JERSEY 08542 Executive Officer Director Benjamin Cravatt c/o Cardinal Partners, 230 Nassau Street Princeton NJ NEW JERSEY 08542 Director Biotechnology No Revenues 06c false 2016-03-31 false true false 1 4000000 3504616 495384 false 1 0 0 0 false Vividion Therapeutics, Inc. John K. Clarke John K. Clarke President 2016-04-11